Phenotype of tumor lymphatic vessels is a prognostic factor in human tongue squamous cell carcinoma

Introduction

Lymph node metastasis is a key prognostic indicator for cancer and a guide for deciding the tumor treatment (1–3). In the event of lymph node metastasis, tumor lymphatic vessels are crucial as the tumor cells enter the lymphatic vessels, migrate inside them and settle on the lymph nodes (4). A number of studies were performed on blood vessels (5–7) and the molecular mechanisms involved in the development and maintenance of blood vessels were largely revealed (8,9). However, lymphangiogenesis and its roles in pathologic conditions have yet to be elucidated.

The peri-tumoral environment is crucial in lymph node metastasis. However, it remains unclear whether lymphatic dissemination is dependent on cancer cell infiltration of newly formed lymphatic vessels that are induced by the tumor or pre-existing lymphatic vessels at peripheral sites of the tumor (10–12).

It was reported that lymphangiogenesis is promoted by lymphatic growth factors derived from tumor cells in a paracrine manner (4,13,14). Therefore, the correlation between the phenotypes of tumor lymphatic vessels and clinicopathological characteristics in tongue squamous cell carcinoma (SCC) was investigated.

Materials and methods

Patients and tissue samples

A total of 43 samples were obtained from patients who were clinicopathologically diagnosed as having tongue SCC at the Department of Oral Surgery, Hokkaido University Hospital, Japan. Informed consent was obtained from the patients prior to the samples being used. The experiment was conducted under the ethics rules of Hokkaido University Hospital. The clinicopathological characteristics of these patients are shown in Table I.

Table I Clinical and pathological characteristics of the cases examined.

Table I

Clinical and pathological characteristics of the cases examined.

	No. of patients
Gender
Male/female	31/12
Tumor size
T1/T2	37
T3/T4	6
Nodal involvement
N0→N−	30
N0→N+	6
N+	7
Distant metastasis
M0→M1	2
Mode of invasion
Expansive	26
Infiltrative	17

None of the patients had received pre-operative radiation treatment or chemotherapy. There were 31 male and 12 female patients. The mean age of the patients was 64 years (range 28–91). Tumor size was classified according to the TNM classification of the International Union Against Cancer (UICC). There were 37 T1 and T2 cases, and 6 T3 and T4 cases. At the first medical examination, lymph node metastasis (N+; N1 and N2) was present in 7 cases. During the follow-up period, subsequent lymph node metastasis (N0 to N+) occurred in 6 of 36 primary N0 patients and distant metastasis in 2 of 43 M0 cases. Lymph node metastasis (primary and subsequent) and distant metastasis are indicative of a poor prognosis. Therefore, the cases that had lymph node metastasis and/or distant organ metastasis were divided into high metastatic potential cases (high-metastatic) and cases without any metastasis as low metastatic potential (low-metastatic). In this study, there were 14 cases of high-metastatic (7 N+, including 1 N+M0 to N+M1, 6 N0 to N+ and 1 N0M0 to M1) and 29 cases of low-metastatic.

Immunohistochemical staining

D2-40 was used to detect peri-tumoral lymphatic vessels. Monoclonal antibody D2-40 was originally raised against M2A, a 40,000 kDa O-linked sialoglycoprotein that is expressed in testicular germ cell neoplasias. D2-40 was later shown to react with lymphatic endothelium in formalin-fixed, paraffin-embedded tissues and solid tumors (14).

Serial 4-μm sections were cut from formalin-fixed, paraffin- embedded tissue blocks, and were then dewaxed and rehydrated through sequential changes of alcohol and distilled water. The slides were boiled in 10 mM sodium citrate buffer (pH 6.0) for 3 min and incubated for 5 min in 0.3% hydrogen peroxide, followed by incubation with 1% BSA for 10 min. The slides were then incubated with primary antibodies D2-40 (1:50 dilution; Signet Laboratories, Dedham, MA, USA) and MIB-1 (1:100 dilution; Dako, Tokyo, Japan) for 1 h at room temperature. After being washed with PBS, the sections were incubated with the Histofine Simple Stain PO (M) horseradish peroxidase-conjugated anti-mouse secondary antibody (Nichirei, Tokyo, Japan) for 40 min and washed in PBS. The color was developed by incubation with the EnVision kit/HRP (DAB; Dako). The slides were then counterstained with hematoxylin and mounted.

Assessment of immunohistochemistry

Lymphatic vessels in peri-tumoral tissue detected by D2-40

The tumor lymphatic vessels were divided into: micro and large lymphatic vessels, based on diameter. Areas within 500 μm from the tumor marginal portion were examined under high-power fields. Lymphatic vessels with diameters <30 μm were defined as micro lymphatic vessels (MLVs) and those with >30 μm as large lymphatic vessels (LLVs). Submucosal lymphatic vessels in normal tissue were also examined as normal counterparts. Three areas were randomly selected and the number of the two types of vessels was counted. The lesions were divided into four groups: i) High-MLV group, in which the mean number of MLVs was ≥5; ii) Low-MLL group, in which the mean number of MLVs was <5; iii) High-LLV group, in which the mean number of LLVs was ≥5; and iv) Low-LLV group, in which the mean number of LLVs was <5.

Proliferative activity of lymphatic endothelial cells

The proliferative activity of lymphatic endothelial cells was examined using antibody MIB-1 in 19 tongue SCC samples from serially-sectioned slides treated with antibody D2-40. Lymphatic vessels with at least one MIB-1-positive lymphatic endothelial cell were defined as lymphatic vessels positive for MIB-1. MIB-1-positive lymphatic vessels were evaluated as proliferating lymphatic vessels and the lymphatic proliferation rate was scored as MIB-1-positive lymphatic vessels/total number of lymphatic vessels (15).

DNA density in tumor lymphatic endothelial cells

The DNA density of lymphatic endothelial cells was examined by measuring the chromatin concentration in 28 cases of tongue SCC. Hematoxylin-stained sections were analyzed by an imaging device (Image Pro Plus). Serial sections were immunostained by MIB-1, and MIB-1-positive endothelial cells were eliminated for scoring in order to select endothelial cells in the resting stage.

Statistical analysis

Correlations between clinicopathological data and states of lymphatic vessels were analyzed using the χ2 test. The relationships between lymphatic proliferation and the tumor metastatic potential, as well as between the nuclear DNA density of tumor lymphatic endothelial cells and clinicopathological characteristics were tested using the unpaired t-test and Mann-Whitney U test.

Results

Micro and large lymphatic vessels and clinicopathological factors

D2-40-positive lymphatic vessels in tongue SCC are shown in Fig. 1. Numerous MLVs were located adjacent to the tumor marginal portion in the high-MLV group (High-MLV, Fig. 1A), whereas few lymphatic vessels were observed in the low-MLV group (Low-MLV, Fig. 1B). A total of 20 cases of High-MLV and 23 of Low-MLV were noted. LLVs were arranged irregularly and were located at a distance from the tumor marginal portion than that of MLVs. There were 18 cases of High-LLV (Fig. 2A) and 25 cases of Low-LLV (Fig. 2B).

Figure 1 Immunohistochemical detection of microlymphatic vessels (MLVs) by D2-40. (A) Numerous MLVs were noted in the tumor marginal portion in the High-MLV group. (B) Few lymphatic vessels were observed in the Low-MLV group.

Figure 2 Large lymphatic vessels (LLVs) detected by D2-40. (A) High-LLV vessel group: LLVs were arranged irregularly and located in the tumor marginal portion. (B) The low-LLV group shows the decreased number of vessels.

No correlation was found between the characteristics of the lymphatic vessels and age, gender or T stage. On the other hand, a highly significant correlation was found between cases with high-metastatic and High-MLV (P=0.0034, χ2 test) and High-LLV groups (P=0.00069, χ2 test) (Table II, Fig. 3). In addition, an increasing tendency of the infiltrating mode of invasion and High-MLV (P=0.069) and a significant correlation between cases with an infiltrating invasion pattern of cancer and High-LLV (P=0.00925) were observed (Fig. 4).

Figure 3 A highly significant correlation between high-metastatic cases and both High-MLV and High-LLV groups (P<0.01, χ2 test).

Figure 4 High-MLV and -LLV groups exhibited a correlation with tumor infiltrative growth.

Table II Relationship between lymphatic vessel characteristics and clinicopathological findings.

Table II

Relationship between lymphatic vessel characteristics and clinicopathological findings.

	High-MLV	Low-MLV	High-LLV	Low-LLV
Gender
Male	15	16	14	17
Female	5	7	4	8
Tumor size
T1, T2	16	21	15	22
T3, T4	4	2	3	3
Tumor metastatic potential
High-metastatic	11	3	11	3
Low-metastatic	9	20	7	22
Mode of invasion
Expansive	5	12	3	14
Infiltrative	15	11	15	11

Proliferative activity of lymphatic endothelial cells and tumor metastasis

MIB-1 immunostaining was performed for 19 cases of tongue SCC, using serial sections stained with D2-40. Lymphatic vessels with at least one MIB-1-positive lymphatic endothelial cell were defined as MIB-1-positive lymphatic vessels and tumor lymphatic endothelial cell proliferation was investigated.

The identification of MIB-1-positive lymphatic vessels in the normal tissue samples proved difficult. However, MIB-1-positive lymphatic vessels were increased around the tumor area of tongue SCC. D2-40-positive lymphatic endothelial cells (Fig. 5A) and MIB-1 expression of lymphatic endothelial cells (Fig. 5B) is shown in the serial sections.

Figure 5 MIB-1 expression in tumor lymphatic endothelial cells in serial sections. (A) D2-40-positive MLVs. (B) MIB-1 expression is observed in the nucleus of lymphatic endothelial cells (indicated by the arrows).

MLV and LLV exhibited MIB-1-positive lymphatic endothelial cells. High-metastatic cases had a higher ratio of MIB-1-positive MLVs (23.6%). By contrast, the mean percentage of proliferating lymphatic vessels was 8% in the low-metastatic cases (unpaired one-tailed t-test, P<0.05, Fig. 6). Thus, lymphatic endothelial cells were noted to be actively proliferating in the high-metastatic cases.

Figure 6 Lymphatic endothelial cells were noted to be actively proliferating in the High-metastatic cases (P<0.05).

DNA contents of tumor lymphatic endothelial cells

The nuclear DNA density of tumor lymphatic vessels was estimated in 28 cases. The tumor endothelial cells had a significant higher nuclear DNA density compared to the lymphatic endothelial cells in normal tissue. A higher correlation was observed between the nuclear DNA density of tumor lymphatic endothelial cells and the metastatic potential. The mean DNA density of endothelial cells in the low-metastatic cases was 1.17-fold higher than that in normal tissue, and 1.38-fold higher in the high-metastatic cases, which was statistically significant (two-tailed Mann-Whitney U test, P<0.01, Fig. 7).

Figure 7 A significant correlation between the nuclear DNA density of tumor lymphatic endothelial cells and the metastatic potential. The tumor lymphatic endothelial cells exhibited a higher nuclear DNA density than the normal endothelial cells and the tumor lymphatic endothelial cells in the High-metastatic cases exhibited a higher nuclear DNA density than the Low-metastatic cases and the normal counterparts (P<0.01).

Discussion

Tumor lymphatic vessels were shown to be induced by vascular endothelial cell growth factors (VEGFs) that are secreted by tumor cells, and this induction is thought to promote lymph node metastasis (1,4,16,17). Lymphatic vessels are classified into initial and collecting lymphatic vessels (18). Morphological differences between initial and collecting lymphatic vessels include the size of the vessels and the existence of smooth muscle cells and intraluminal valves. Initial lymphatic vessels are smaller and have primary valves that are composed of partial overlaps between lymphatic endothelial cells that are involved in the activity of lymphatic vessels (18,19). Padera et al (20) reported that newly formed small intratumoral lymphatic vessels did not have any correlation with lymphatic metastasis since intratumoral lymphatic vessels were not functional and enlarged lymphatic vessels were correlated with tumor metastasis. On the other hand, Skobe et al (21) reported that breast cancer cells secreted VEGF-C, which increased intratumoral lymphangiogenesis and resulted in significantly enhanced metastasis to the regional lymph nodes and lungs. Thus, the significance of the lymphatic vessels around tumors remains to be determined.

We examined the correlation between the phenotypes of tumor lymphatic vessels and the clinicopathological characteristics in tongue SCC. Highly significant metastatic potential was observed in cases in the High-MLV and -LLV groups. Skobe et al transplanted VEGF-C-overexpressing breast cancer cell lines into nude mice and found numerous small lymphatic vessels in the stromal tissue of transplanted VEGF-C-overexpressing MDA-MB-435 cells. These authors also reported that VEGF-C-overexpressing tumors were infiltrated throughout the central tumor areas by lymphatic vessels, whereas control tumors were not invaded by lymphatic vessels (21). Our results were in agreement with the report (15) that tumor MLVs may be regarded as newly formed lymphatic vessels, indicating the ability for tumor lymphangiogenesis. Our results suggest that lymph node metastasis of tongue SCC is predicted by estimating lymphatic vessels around the tumor, even in the early stages of tumor progression.

In the High-MLV and -LLV groups, a correlation to the infiltrative growth pattern of tumors was noted. Ueda et al (16) reported that VEGF-C-expressing ovarian carcinoma cell lines showed an invasive phenotype with correlated expression levels of VEGF-C and MMP-2. The precise mechanisms of VEGF-C and MMP-2 expression have yet to be elucidated, but it may be postulated that cases in the high tumor lymphatic vessel group express a high level of VEGF-C as well as MMP-2 or other extracellular matrix-degrading enzymes that may be involved in invasive potential.

We examined the proliferative activity of tumor lymphatic vessels by immunostaining serial sections with MIB-1 and D2-40 antibodies. In 19 cases of tongue SCC, both MLV and LLV had a greater number of MIB-1-positive lymphatic endothelial cells compared to lymphatic vessels in normal tissue. Moreover, the high-metastatic group showed an increasing ratio of MIB-1-positive endothelial cells. These results suggested that newly formed lymphatic vessels were closely associated with regional lymph node metastases.

It is known that the nuclear DNA contents of tumor cells increase due to chromosome abnormalities (22). Malignant tumor cells are known to have a broad range of nuclear DNA content compared to normal or benign neoplastic cells. However, stromal cells in cancer are considered to be intact, including endothelial cells in epithelial tumors. Hida et al reported that tumor vascular endothelial cells exhibit genetic abnormalities (23–25).

We measured the DNA content of tumor lymphatic vessels using an imaging device. The nuclear DNA content was found to increase in tumor lymphatic compared to normal lymphatic endothelial cells. Cases in the high-metastatic group showed an increased DNA content in tumor lymphatic endothelial cells compared to those in the low-metastatic cells. Our results indicate that tumor lymphatic endothelial cells may have genetic abnormalities simialr to those observed in tumor vascular endothelial cells. Further studies are required to determine the characteristics of tumor lymphatic endothelial cells and the inhibitory mechanism of lymph node metastasis, which may contribute to the welfare of patients diagnosed with tongue SCC.

Acknowledgements

This study was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

References